Red blood cell parameters as biomarkers of retinopathy of prematurity in preterm infants born before 30&#xa0;weeks of gestation

Retinal DiseasesFurther Publications

The association between red blood cell transfusion timing and the development of retinopathy of prematurity: Application of the two-phase theory

Acta Ophthalmol

El Emrani S, Derks LA, Tjiam AM, van Bohemen M, Termote JUM, van der Meeren LE, Reiss IKM, Taal HR, Lopriore E, Schalij-Delfos NE

doi: 10.1111/aos.17471

Retinal Diseases

Trends in Retinopathy of Prematurity Among Preterm Infants in California, 2012 to 2021

JAMA Ophthalmol

Quinn MK, Lee HC, Profit J, Chu A

doi: 10.1001/jamaophthalmol.2024.3909

Retinal Diseases

Predicting the risk of treatment-requiring retinopathy of prematurity in preterm infants in Greece. External validation of DIGIROP prognostic models

Acta Ophthalmol

Moutzouri S, Pivodic A, Haidich AB, Seliniotaki AK, Lithoxopoulou M, Tsakalidis C, Hellström A, Ziakas N, Mataftsi A

doi: 10.1111/aos.16788

Retinal DiseasesFurther Publications

Efficacy and Safety of Mydriatic Microdrops for Retinopathy of Prematurity Screening: The MyMiROPS Randomized Clinical Trial

JAMA Ophthalmol

Seliniotaki AK, Lithoxopoulou M, Virgiliou C, Gika H, Dokoumetzidis A, Bougioukas KI, Raikos N, Diamanti E, Ziakas N, Haidich AB, Mataftsi A

doi: 10.1001/jamaophthalmol.2024.5462

Retinal Diseases

Screening for retinopathy of prematurity in China: a five-year cohort study in seven screening centers

BMC Ophthalmol

Zhong Y, Lin X, Yang Y, He L, Li N, Lu J, Zhou Y, Zhang R, Wang Y, Zhang Z, Yang M, Yin H, Zhao M, Li X, Liang J, Cheng Y

doi: 10.1186/s12886-024-03836-5

Blindness and Vision ImpairmentRetinal Diseases

Retinopathy of Prematurity: Incidence, Risk Factors, and Treatment Outcomes in a Tertiary Care Center

J Clin Med

Blazon MN, Rezar-Dreindl S, Wassermann L, Neumayer T, Berger A, Stifter E

doi: 10.3390/jcm13226926

Retinal Diseases

Retinal vascularization rate predicts retinopathy of prematurity and remains unaffected by low-dose bevacizumab treatment

Am J Ophthalmol

Chang E, Josan A, Purohit R, Aslam SA, Hartley C, Patel CK, Xue K

doi: 10.1016/j.ajo.2025.02.040

Retinal Diseases

Prediction of retinopathy of prematurity development and treatment need with machine learning models

BMC Ophthalmol

Durmaz Engin C, Ozturk T, Ozkan O, Oztas A, Selver MA, Tuzun F

doi: 10.1186/s12886-025-04025-8

Retinal Diseases

The effect of high-dose erythropoietin perinatally on retinal function in school-aged children born extremely or very preterm

Am J Ophthalmol

Sisera L, Hanson JVM, Füglistaler J, Jeltsch BM, Patzelt S, Wehrle FM, Hagmann CF, Fauchère JC, Heyard R, Gerth-Kahlert C

doi: 10.1016/j.ajo.2024.06.027

Ophthalmology

Red blood cell parameters as biomarkers of retinopathy of prematurity in preterm infants born before 30 weeks of gestation

Related content

The association between red blood cell transfusion timing and the development of retinopathy of prematurity: Application of the two-phase theory

Trends in Retinopathy of Prematurity Among Preterm Infants in California, 2012 to 2021

Predicting the risk of treatment-requiring retinopathy of prematurity in preterm infants in Greece. External validation of DIGIROP prognostic models

Efficacy and Safety of Mydriatic Microdrops for Retinopathy of Prematurity Screening: The MyMiROPS Randomized Clinical Trial

Screening for retinopathy of prematurity in China: a five-year cohort study in seven screening centers

Retinopathy of Prematurity: Incidence, Risk Factors, and Treatment Outcomes in a Tertiary Care Center

Retinal vascularization rate predicts retinopathy of prematurity and remains unaffected by low-dose bevacizumab treatment

Prediction of retinopathy of prematurity development and treatment need with machine learning models

The effect of high-dose erythropoietin perinatally on retinal function in school-aged children born extremely or very preterm